Illumina MiSeq i100Plus sequencing system

Forecast overview

Subagency

FDA

NAICS

423490

Program office

HFP ACQUISITION

PA #2 6/16 approved The purpose of the request is to purchase a new model desktop genomic sequencing system from Illumina that has better technology and build, higher throughput, greater efficiency and accuracy, and less cost per genome compared to the older models. The new model of sequencing instrument shall assist the OAMT scientists on the in-silico design and development of all FDA sequencing applications for foodborne pathogens (bacteria such as Salmonella spp., Listeria monocytogenes and STEC, and viruses and parasites). We will also utilize the instrument to develop and optimize next generation sequencing laboratory protocols and to compare new applications (such as Targeted Amplicon Sequencing) with other genomic methods like whole genome and metagenome sequencing. One instrument for MOD1 (DFES) & one instrument for CPK1 (DFSG) & one instrument for Moffett (DFPST - unfunded)

Source

Source

HHS SBCX Forecast Export

Source file

Forecast.csv

Official source

Agency forecast source

Last verified

2026-08-31

Agency-published contact: · TBD@fda.hhs.gov

Forecast research and capture tools

Compare this forecast with broader federal opportunity volume and mix.

• 2026 Federal Opportunity Benchmark
• Federal Opportunity Research hub
• Best capture management software guide
• Free opportunity alerts for upcoming notices